US Stock MarketDetailed Quotes

LVTX LAVA Therapeutics

Watchlist

1.110
-0.090-7.50%

Close Dec 13 16:00 ET

1.140
+0.030+2.70%

Post 20:01 ET

29.19MMarket Cap-1.10P/E (TTM)

LAVA Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

471.24%6.99M

-65.09%6.77M

-86.63%353K

-99.65%53K

998.08%5.14M

19.77%1.22M

262.45%19.39M

147.65%2.64M

Operating revenue

--0

471.24%6.99M

-65.09%6.77M

-86.63%353K

-99.65%53K

998.08%5.14M

19.77%1.22M

262.45%19.39M

147.65%2.64M

Cost of revenue

3.48M

154K

10K

2.39M

930K

Gross profit

2,278.23%6.99M

-83.05%3.29M

-92.46%199K

-99.72%43K

487.82%2.75M

-71.23%294K

262.45%19.39M

2.64M

Operating expense

4.78%11.29M

-42.56%9.36M

-35.34%8.94M

-14.18%46.54M

-60.05%5.64M

-36.01%10.77M

41.16%16.3M

17.89%13.83M

10.76%54.23M

35.73%14.12M

Selling and administrative expenses

-2.55%2.79M

-18.18%3.03M

-24.55%2.94M

-9.90%12.73M

-36.27%2.28M

-8.84%2.86M

16.51%3.7M

-8.19%3.89M

17.52%14.12M

-5.02%3.58M

-General and administrative expense

-2.55%2.79M

-18.18%3.03M

-24.55%2.94M

-9.90%12.73M

-36.27%2.28M

-8.84%2.86M

16.51%3.7M

-8.19%3.89M

17.52%14.12M

-5.02%3.58M

Research and development costs

7.43%8.5M

-49.71%6.34M

-39.57%6.01M

-15.69%33.81M

-68.12%3.36M

-42.24%7.91M

50.51%12.6M

32.63%9.94M

8.55%40.11M

58.88%10.54M

Operating profit

-5.20%-11.29M

30.89%-9.36M

85.58%-1.95M

-24.15%-43.25M

52.59%-5.44M

-582.81%-10.73M

-22.29%-13.55M

-26.39%-13.54M

20.12%-34.84M

-22.95%-11.48M

Net non-operating interest income expense

-0.49%805K

16.19%811K

31.28%810K

1,055.64%2.97M

79.62%846K

1,974.36%809K

875.56%698K

478.53%617K

141.12%257K

411.92%471K

Non-operating interest income

-0.49%805K

16.19%811K

31.28%810K

844.54%3.2M

--1.08M

--809K

--698K

--617K

--339K

----

Non-operating interest expense

----

182.93%232K

----

-86.88%82K

----

Other net income (expense)

-251.94%-1.72M

38.93%339K

169.48%658K

-148.31%-1.41M

52.06%-1.84M

-54.99%1.13M

-92.22%244K

-185.16%-947K

43.28%2.92M

-389.81%-3.84M

Gain on sale of security

-251.94%-1.72M

38.93%339K

169.48%658K

-148.31%-1.41M

52.06%-1.84M

-54.99%1.13M

-92.22%244K

-185.16%-947K

43.28%2.92M

-389.81%-3.84M

Income before tax

-38.86%-12.2M

34.85%-8.21M

96.51%-484K

-31.70%-41.7M

56.65%-6.44M

-993.79%-8.79M

-56.95%-12.6M

-42.06%-13.87M

24.98%-31.66M

-81.92%-14.85M

Income tax

92.00%96K

-12.37%85K

-2.82%69K

12.05%279K

-8.96%61K

6.38%50K

27.63%97K

20.34%71K

58.60%249K

17.54%67K

Net income

-39.16%-12.3M

34.68%-8.3M

96.03%-553K

-31.55%-41.97M

56.43%-6.5M

-1,044.02%-8.84M

-56.67%-12.7M

-41.93%-13.94M

24.67%-31.91M

-81.47%-14.92M

Net income continuous Operations

-39.16%-12.3M

34.68%-8.3M

96.03%-553K

-31.55%-41.97M

56.43%-6.5M

-1,044.02%-8.84M

-56.67%-12.7M

-41.93%-13.94M

24.67%-31.91M

-81.47%-14.92M

Minority interest income

Net income attributable to the parent company

-39.16%-12.3M

34.68%-8.3M

96.03%-553K

-31.55%-41.97M

56.43%-6.5M

-1,044.02%-8.84M

-56.67%-12.7M

-41.93%-13.94M

24.67%-31.91M

-81.47%-14.92M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-39.16%-12.3M

34.68%-8.3M

96.03%-553K

-31.55%-41.97M

56.43%-6.5M

-1,044.02%-8.84M

-56.67%-12.7M

-41.93%-13.94M

24.67%-31.91M

-81.47%-14.92M

Basic earnings per share

-35.29%-0.46

35.42%-0.31

96.23%-0.02

-27.64%-1.57

61.40%-0.22

-950.00%-0.34

-54.84%-0.48

-39.47%-0.53

42.52%-1.23

-50.00%-0.57

Diluted earnings per share

-35.29%-0.46

35.42%-0.31

96.23%-0.02

-27.64%-1.57

61.40%-0.22

-950.00%-0.34

-54.84%-0.48

-39.47%-0.53

42.52%-1.23

-50.00%-0.57

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	471.24%6.99M	-65.09%6.77M	-86.63%353K	-99.65%53K	998.08%5.14M	19.77%1.22M	262.45%19.39M	147.65%2.64M
Operating revenue	--0	--0	471.24%6.99M	-65.09%6.77M	-86.63%353K	-99.65%53K	998.08%5.14M	19.77%1.22M	262.45%19.39M	147.65%2.64M
Cost of revenue	0	0	0	3.48M	154K	10K	2.39M	930K	0	0
Gross profit	0	0	2,278.23%6.99M	-83.05%3.29M	-92.46%199K	-99.72%43K	487.82%2.75M	-71.23%294K	262.45%19.39M	2.64M
Operating expense	4.78%11.29M	-42.56%9.36M	-35.34%8.94M	-14.18%46.54M	-60.05%5.64M	-36.01%10.77M	41.16%16.3M	17.89%13.83M	10.76%54.23M	35.73%14.12M
Selling and administrative expenses	-2.55%2.79M	-18.18%3.03M	-24.55%2.94M	-9.90%12.73M	-36.27%2.28M	-8.84%2.86M	16.51%3.7M	-8.19%3.89M	17.52%14.12M	-5.02%3.58M
-General and administrative expense	-2.55%2.79M	-18.18%3.03M	-24.55%2.94M	-9.90%12.73M	-36.27%2.28M	-8.84%2.86M	16.51%3.7M	-8.19%3.89M	17.52%14.12M	-5.02%3.58M
Research and development costs	7.43%8.5M	-49.71%6.34M	-39.57%6.01M	-15.69%33.81M	-68.12%3.36M	-42.24%7.91M	50.51%12.6M	32.63%9.94M	8.55%40.11M	58.88%10.54M
Operating profit	-5.20%-11.29M	30.89%-9.36M	85.58%-1.95M	-24.15%-43.25M	52.59%-5.44M	-582.81%-10.73M	-22.29%-13.55M	-26.39%-13.54M	20.12%-34.84M	-22.95%-11.48M
Net non-operating interest income expense	-0.49%805K	16.19%811K	31.28%810K	1,055.64%2.97M	79.62%846K	1,974.36%809K	875.56%698K	478.53%617K	141.12%257K	411.92%471K
Non-operating interest income	-0.49%805K	16.19%811K	31.28%810K	844.54%3.2M	--1.08M	--809K	--698K	--617K	--339K	----
Non-operating interest expense	----	----	----	182.93%232K	----	----	----	----	-86.88%82K	----
Other net income (expense)	-251.94%-1.72M	38.93%339K	169.48%658K	-148.31%-1.41M	52.06%-1.84M	-54.99%1.13M	-92.22%244K	-185.16%-947K	43.28%2.92M	-389.81%-3.84M
Gain on sale of security	-251.94%-1.72M	38.93%339K	169.48%658K	-148.31%-1.41M	52.06%-1.84M	-54.99%1.13M	-92.22%244K	-185.16%-947K	43.28%2.92M	-389.81%-3.84M
Income before tax	-38.86%-12.2M	34.85%-8.21M	96.51%-484K	-31.70%-41.7M	56.65%-6.44M	-993.79%-8.79M	-56.95%-12.6M	-42.06%-13.87M	24.98%-31.66M	-81.92%-14.85M
Income tax	92.00%96K	-12.37%85K	-2.82%69K	12.05%279K	-8.96%61K	6.38%50K	27.63%97K	20.34%71K	58.60%249K	17.54%67K
Net income	-39.16%-12.3M	34.68%-8.3M	96.03%-553K	-31.55%-41.97M	56.43%-6.5M	-1,044.02%-8.84M	-56.67%-12.7M	-41.93%-13.94M	24.67%-31.91M	-81.47%-14.92M
Net income continuous Operations	-39.16%-12.3M	34.68%-8.3M	96.03%-553K	-31.55%-41.97M	56.43%-6.5M	-1,044.02%-8.84M	-56.67%-12.7M	-41.93%-13.94M	24.67%-31.91M	-81.47%-14.92M
Minority interest income
Net income attributable to the parent company	-39.16%-12.3M	34.68%-8.3M	96.03%-553K	-31.55%-41.97M	56.43%-6.5M	-1,044.02%-8.84M	-56.67%-12.7M	-41.93%-13.94M	24.67%-31.91M	-81.47%-14.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-39.16%-12.3M	34.68%-8.3M	96.03%-553K	-31.55%-41.97M	56.43%-6.5M	-1,044.02%-8.84M	-56.67%-12.7M	-41.93%-13.94M	24.67%-31.91M	-81.47%-14.92M
Basic earnings per share	-35.29%-0.46	35.42%-0.31	96.23%-0.02	-27.64%-1.57	61.40%-0.22	-950.00%-0.34	-54.84%-0.48	-39.47%-0.53	42.52%-1.23	-50.00%-0.57
Diluted earnings per share	-35.29%-0.46	35.42%-0.31	96.23%-0.02	-27.64%-1.57	61.40%-0.22	-950.00%-0.34	-54.84%-0.48	-39.47%-0.53	42.52%-1.23	-50.00%-0.57
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data